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At present, the immune response of pigs in relation to Staphylococcus aureus carriage is poorly understood. This
study was aimed at investigating the dynamics of the anti-staphylococcal humoral immune response in
methicillin-susceptible S. aureus (MSSA)-positive piglets and at assessing the effect of the experimental introduction
of a methicillin-resistant S. aureus (MRSA) Sequence Type (ST) 398 strain. Therefore, serum samples were collected at
different times from 31 weaned piglets originating from four different sows. Twenty-four out of the 31 piglets were
challenged with MRSA ST398. The serum samples were analyzed for IgG antibodies to 39 S. aureus antigens, using a
multiplex bead-based assay (xMAP technology, Luminex Corporation). Though antibody responses showed broad
inter-individual variability, serological results appeared to be clustered by litter of origin. For most antigens, an
age-related response was observed with an apparent increase in antibody titers directed against staphylococcal
microbial surface components recognizing adhesive matrix molecules (MSCRAMM), which have been shown to play
a role in S. aureus colonization. In most animals, antibody titers directed against staphylococcal toxins or
immune-modulating proteins decreased with age, possibly reflecting the absence of bacterial invasion. The
introduction of MRSA ST398 did not elicit a significant humoral immune reaction.
This study describes, for the first time, the humoral immune response in weaned pigs colonized with S. aureus.Introduction
Staphylococcus aureus is an opportunistic pathogen resid-
ing on the skin and mucous membranes of humans and
several animal species [1,2]. In humans, it has been shown
that nasal S. aureus carriage increases the risk of infection
by a factor three, with patients being mostly affected by
their autologous strain [3]. Conversely, a lower risk for
bacteremia-related death has been reported in S. aureus
carriers compared to non-carriers [3].
The differences in risk and outcome of S. aureus infec-
tions between human carriers and non-carriers have
been associated with the humoral immune response,
protecting carriers from bacteremia mediated death and
non-carriers from S. aureus colonization. This response
might include antibodies against staphylococcal micro-
bial surface components recognizing adhesive matrix* Correspondence: flcro@coda-cerva.be
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reproduction in any medium, provided the ormolecules (MSCRAMM) and against virulence factors
involved in evading or destroying host defenses [4-8].
The extensive spread of livestock-associated methicillin-
resistant S. aureus (LA-MRSA) clonal complex (CC) 398
and CC9 among pigs has raised questions on the mechan-
isms establishing the interactions between MRSA and pigs
[9-11]. As in humans, the pigs’ immune system might play
an important regulatory role. However, at present, know-
ledge on the (humoral) immune response of pigs to S. aureus
is lacking. Therefore, our aim was to increase the under-
standing of this topic.
In the present study, we examined the kinetics of anti-
staphylococcal antibodies in weaned piglets colonized
with S. aureus by determining the levels of IgG anti-
bodies to 9 MSCRAMM, 23 staphylococcal toxins and 7
immune-modulating proteins in serum samples. In
addition, we investigated the effect of the introduction
of a MRSA Sequence Type (ST) 398 strain on the pig-
lets’ humoral immune response.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Animals and serum samples
Venous blood samples were obtained from 31 healthy
weaned cross-bred piglets (Landrace × Piétrain, Malèves-
St. Marie, Belgium) previously described in a transmission
study with MRSA strain C26 (ST398, spa type t011,
SCCmec type V) [12]. Briefly, at 21 days of age, piglets
obtained from four different sows (1–4), were transported
to the experimental site and distributed into three experi-
mental groups (1–3) consisting of eight piglets, and one
negative control group of seven piglets. All three experi-
mental groups included four male and female pairs origin-
ating from each of the four sows. The negative control
group was composed of three male and female pairs, ori-
ginating from sows 1–3, and a single female piglet originat-
ing from the fourth sow. The transmission study was
performed by introducing two MRSA-positive animals
(i.e. seeders that were inoculated with ~9 × 108 CFU of
MRSA strain C26 two days before their introduction), at
30 days of age, in each experimental group composed of six
MRSA-negative piglets. Swab samples from all animals
were collected separately from both anterior nares, the skin
behind the ears and the perineum, during a period of six
weeks to determine their S. aureus carriage state. For the
present study, serum samples were taken before the start of
the transmission experiment (six days before introduction
of the MRSA positive animals – age: 24 days) and at 8, 15,
22, 29 and 36 days post introduction, corresponding to 38,
45, 52, 59 and 66 days of age.
Testing at 24 days of age revealed that all animals were
positive for methicillin-susceptible S. aureus (MSSA)
ST9 (spa type t3446 or t337). In all 24 animals that were
included in the MRSA transmission study, MSSA and/or
MRSA were detected until the end of the trial [12]. In
the seven animals of the negative control group that
were not colonized with MRSA strain C26, MSSA was
not detected after the second sampling occasion, except
once for one animal at the end [12]. To evaluate the ef-
fect of MRSA strain C26 introduction on the piglets’
humoral response, animals were classified as persistent
MRSA carriers (n = 8) if ≥ 80% of the samples taken at
different time points after the introduction of MRSA
were MRSA positive. Animals were classified as non-
MRSA carriers (n = 7) if all samples were MRSA nega-
tive; the other animals were classified as intermittent
MRSA carriers (n = 16).S. aureus strain characteristics
The presence of 39 virulence-associated genes (Table 1)
was determined in one MSSA isolate of each spa type
originating from one randomly selected animal at 24 days
of age and in MRSA strain C26 by DNA microarray by
Alere Technologies GmbH, Jena, Germany [13-15].Anti-staphylococcal antibody assay
Levels of IgG directed against 39 S. aureus proteins were
quantified simultaneously using a bead-based flow cyto-
metry technique (xMap; Luminex Corporation, Austin,
TX, USA) based on a previously described method [5,6].
Briefly, serum samples were diluted 1:50 in PBS-BN (PBS,
1% bovine serum albumin, and 0.05% sodium azide
[pH7.4]) for measurements of antigen-specific IgG. Per
diluted sample, 50 μL was incubated with the different
fluorescence-coloured antigen-coupled microspheres, i.e.
3000 beads per antigen per well, in a 96-well filter micro-
plate (Millipore, Amsterdam, The Netherlands) for 35 min
at room temperature on a Thermomixer plate shaker
(Eppendorf, Nijmegen, The Netherlands). After washing
the plate twice with PBS-BN and aspiration by vacuum
manifold, 50 μL of a 1:100 dilution of R-phycoerythrin
(RPE)-labelled anti-swine IgG (Jackson Immuno Research,
Westgrove, PA, USA) was added. Following a second in-
cubation (35 min at room temperature) and washing step,
the microspheres were resuspended in 100 μL PBS-BN.
Measurements were performed on the Luminex 100 in-
strument (BMD, Croissy-Beaubourg, France) using Lumi-
nex software (version 2.2). Tests were performed in
independent duplicates and the median fluorescence in-
tensity (MFI) values, reflecting semi-quantitative antibody
levels, were averaged. Duplicates with a coefficient of vari-
ance (CV) higher than 25% were considered as not repro-
ducible and deleted from the data set. If antibody binding
was observed in the serum samples incubated with the
control beads (i.e. beads without protein coupled on their
surface), the nonspecific MFI values were subtracted from
the antigen-specific results. Swine pooled serum, collected
from 85 healthy pigs, incubated with protein-coupled
beads was used as a positive control. Similarly, PBS-BN
was included as a negative control.
Statistical analysis
Independent-sample median test was performed to de-
termine the distribution across the animals grouped by
litter of origin with a 0.05 threshold at 24 days of age
(SPPS software, version 19) [16].
The kinetics of anti-staphylococcal antibodies were
analyzed using linear regression during a 6-week period.
A linear mixed model including fixed and random
effects was used by means of the MIXED procedure of
SPPS software, version 19. The model was fitted using
the Maximal Likelihood estimation (ML) method and
used to evaluate the effect of MRSA ST398 introduction
on the antibody profiles of the piglets. Age (in days),
group (non-MRSA carriers vs. persistent and intermit-
tent MRSA carriers) and gender (male vs. female) were
introduced as fixed effects. To increase the degrees of
freedom in the statistical analysis, the factor “age” was not
included as a repeated measure, though the different
Table 1 DNA microarray results for the 39 S. aureus antigens studied by Luminex assay
Antigens of S. aureus Full name DNA microarray results
ST398-V/t011 ST9/t3446 ST9/t337
MSCRAMM
ClfA clumping factor A + + +
ClfB clumping factor B + + +
FnbpA fibronectin binding protein A + + +
FnbpB fibronectin binding protein B + + +
IsdA iron-responsive surface determinant A + + +
IsdH iron-responsive surface determinant H ND ND ND
SasG surface protein G - - -
SdrD serine-aspartate dipeptide repeat D + + +
SdrE serine-aspartate dipeptide repeat E ND ND ND
Immune-modulating proteins
CHIPS chemotaxis inhibitory protein of S. aureus - - -
SCIN staphylococcal complement inhibitor - - -
SSL1 S. aureus surface protein like 1 + + +
SSL3 S. aureus surface protein like 3 -* + +
SSL5 S. aureus surface protein like 5 + + +
SSL9 S. aureus surface protein like 9 + + +
SSL11 S. aureus surface protein like 11 - - -
Leucotoxins
HlgB haemolysin beta +** + +
LukD leukocidin D - - -
LukE leukocidin E - - -
LukF leukocidin F + + +
LukS leukocidin S + + +
Staphylococcal enterotoxins
α-toxin alfa-toxin + + +
SEA staphylococcal enterotoxin A - - -
SEB staphylococcal enterotoxin B - - -
SEC staphylococcal enterotoxin C - - -
SED staphylococcal enterotoxin D - - -
SEE staphylococcal enterotoxin E - - -
SEG staphylococcal enterotoxin G - + +
SEH staphylococcal enterotoxin H - - -
SEI staphylococcal enterotoxin I - + +
SEJ staphylococcal enterotoxin J - - -
SEM staphylococcal enterotoxin M - + +
SEN staphylococcal enterotoxin N - + +
SEO staphylococcal enterotoxin O - + +
SEQ staphylococcal enterotoxin Q - - -
SER staphylococcal enterotoxin R - - -
TSST-1 toxic shock syndrome toxin-1 - - -
Exfoliative toxins
ETA exfoliative toxin A - - -
ETB exfoliative toxin B - - -
ND: Not determined.
*- for Staphylococcal Superantigen like protein 8/SSL3, + for Staphylococcal Superantigen like protein B3.
**+ for un-truncated Haemolysin Beta.
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data of the study. However, the interaction term “age*group”
was added to correct for the time effect. In this way changes
between groups over time could be observed. The piglets
and their respective mothers (i.e. the interaction term “pig*-
sow”) were introduced as random effect to account for pig-
let and sow individual effects and disturbances.Results
S. aureus strain characteristics
The presence of genes encoding virulence factors included
in the antibody assay in the studied S. aureus strains is
mentioned in Table 1.Figure 1 Median of the median fluorescence intensity (MFI) values re
6 weeks. Four trends were observed: increasing antibody levels (A), increa
antibody levels (E,F) and nearly no varying antibody levels over time (G).Anti-staphylococcal antibody response
Overall antibody response over time
IgG antibodies were detected in the positive control
sample (swine pooled serum) for all but one (i.e. SEB)
antigen. The negative control (PBS-BN) incubated with
protein-coupled beads resulted in low MFI values (< 9).
Serum incubated with control beads resulted in median
MFI values of 208 (range: 83–606). Two samples were
deleted from the data set, corresponding to serum of an
animal at 24 days of age and one at 59 days of age, be-
cause the first one had high control bead levels (MFI-
value of 1969) and the other one showed MFI-values
similar to the PBS-BN. Both piglets belong to the per-
sistent MRSA carrier group.flecting IgG levels for 33 S. aureus antigens in 31 piglets over
sing antibody levels followed by a slow decline (B,C,D), decreasing
Crombé et al. Veterinary Research 2013, 44:4 Page 5 of 10
http://www.veterinaryresearch.org/content/44/1/4Median MFI values reflecting IgG levels against six
out of 39 S. aureus antigens were nearly absent in the
piglets’ serum samples, i.e. SEB, SEE, SEH, SEI, SEN and
SEO (median MFI < 1) (data not shown). As a result,
the antibody response against these antigens will not be
further discussed.
As shown in Figure 1, four antibody response trends
could be observed over the 6-week period: i. continu-
ously increasing antibody levels over time (A), ii. in-
creasing antibody levels followed by a slow decline over
time (B,C,D), iii. a high antibody level at the start that
decreased over time (E,F) and iv. nearly no varying anti-
body levels over time (G). In line with these observa-
tions, a significant “time” effect was observed (p < 0.05)
for all but two of the 33 antigens (i.e. ETB and SEC)
(data not shown).
Antigen-specific antibody levels classified per sow
Although antibody levels varied among the animals, the
IgG levels directed against several antigens appeared to be
grouped by litter of origin (Figure 2). These data are pre-
sented in an additional data file (see Additional file 1). An
independent-sample median test revealed that the distri-
butions across the animals grouped by litter of origin were
significantly different for 24 out of the 33 antigens tested
at 24 days of age (p < 0.05) (Figure 2). Also, when focusing
on the antigens with decreasing global antibody profiles
(i.e., α-toxin, HlgB, SSL1, SSL3, SSL5, SSL9, SSL11, LukE
and LukS), a litter-related decrease was perceived
over time (Figure 3). Remarkably though as a generalFigure 2 Median fluorescence intensity (MFI) value reflecting
IgG levels for 33 S. aureus antigens in 30 piglets classified per
litter at 24 days of age. Each dot represents a single piglet, green
squares represent litter 1, blue diamonds represent litter 2, red
triangles represent litter 3 and orange spheres represent litter 4.
Median IgG levels are indicated by horizontal lines. *Significant with
independent-sample median test across animals grouped by litter at
24 days of age (α-toxin, FnbpB, SED, SSL1, SSL3 and SSL5, p < 0.001;
ClfA, ClfB, ETA, HlgB, IsdA, IsdH, LukE, LukF, SdrE, SEJ, SSL9 and SSL11,
p < 0.005; ETB, LukD, p < 0.01; SasG, SdrD, SEC and TSST-1, p < 0.05);
† Unable to compute for SEQ.trend, the levels of antibodies against α-toxin and SSL1
declined, it appeared that IgG levels increased for certain
animals at 59 and 66 days of age (Figure 4).
Effect of MRSA introduction on antibody profiles
The ‘group’ effect was significant for one antigen (i.e. ClfB,
p = 0.014), with mean IgG levels being significantly lower
in persistent MRSA carriers compared with non-MRSA
carriers (p = 0.031). Mean IgG levels directed against ClfB
were lower (though not significant) in intermittent MRSA
carriers compared with non-MRSA carriers (p = 0.09)
(data not shown).
The humoral immune response to ClfA, ClfB, ETB and
FnbpB differed significantly between groups over time
(age*group interaction; p < 0.001, p = 0.001, p = 0.035 and
p = 0.006, respectively). At the peak of the IgG response
(38 days of age), antibody levels directed against ClfA and
ETB were significantly higher in non-MRSA carriers com-
pared to persistent MRSA carriers (p < 0.001; p = 0.003)
and intermittent MRSA carriers (p = 0.007; p = 0.006)
(Figure 5). For ClfB, antibody levels were significantly
higher in non-MRSA carriers compared to intermittent
MRSA carriers (p < 0.001) though not compared to per-
sistent MRSA carriers (p = 0.12) (Figure 5). Conversely,
for FnbpB, antibody levels were significantly higher in
non-MRSA carriers compared to persistent MRSA carriers
(p = 0.003) though not compared to IC (p = 0.058) (Figure 5).
However, for ETB, one non-MRSA carrier had a very high
IgG level at 38 days of age and when deleting this record
from the dataset a significant difference was no longer
observed (age*group interaction; p = 0.77).
When deleting an additional non-MRSA carrier from the
dataset, with high levels directed against ClfA and FnbpB
at 38 days of age, a significant difference was also no longer
observed (age*group interaction; p = 0.094 and p = 0.075).
For each sampling occasion, mean IgG levels ± 95% CI
of intermittent MRSA carriers, persistent MRSA carriers
and non-MRSA carriers are presented in an additional
data file (see Additional file 2).
Discussion
To our knowledge, this is the first study on humoral im-
mune response against S. aureus in weaned pigs. We used a
multiplex bead-based assay (xMAP technology, Luminex
Corporation) to simultaneously quantify antibodies against
39 staphylococcal proteins in small-volume serum samples.
This high-throughput immunological test is of particular
interest since it gives the opportunity to simultaneously study
the humoral response of healthy or diseased individuals to a
specific pathogen towards large sets of antigens [5,6,17,18].
Antibodies against all but one of the 39 antigens (i.e.
SEB) were detected in the swine pooled serum standard
positive control. Therefore, the present study does not
allow drawing conclusions with regards to serological
Figure 3 Median fluorescence intensity (MFI) values reflecting IgG levels against α-toxin, HlgB, SSL1, SSL3, SSL5, SSL9, SSL11, LukE and
LukS in 31 piglets classified per litter over a 6-week period. Each dot represents a single piglet, green squares represent litter 1, blue diamonds
represent litter 2, red triangles represent litter 3 and orange spheres represent litter 4. Median IgG levels are indicated by horizontal lines.
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absent in S. aureus strains of animal origin [19], which
was also the case for the investigated strains, it is un-
likely that pigs produced antibodies against this antigen.
Four trends were observed among the dynamics of anti-
staphylococcal antibody response in all piglets colonized
with S. aureus: i. a main increase in response over time, ii.
an increase in response followed by a slow decline, iii. a
main decrease in response over time or iv. almost no
change in response. Given that the observational period of
the present study started at weaning, it is likely that serum
IgG directed against certain antigens are de novo synthe-
sized by the piglets whereas others are of maternal origin
[20,21]. Increasing antibody titers indicate de novosynthesis, whereas antibodies with decreasing titers are
most probably from maternal origin. Interestingly, most
antibodies with increasing levels were directed to antigens
belonging to the family of the MSCRAMM, which are
known to be expressed by actively dividing bacteria and are
essential in the colonization process of S. aureus [2,22-24].
This indicates that maternal antibodies do not protect pig-
lets from colonization. Indeed, it has been described that
piglets derived from S. aureus-positive sows are more
likely to become S. aureus colonized [25]. In contrast,
antibodies with decreasing levels were mostly directed
against staphylococcal toxins or immune-modulating pro-
teins interfering with host defences and playing a role dur-
ing staphylococcal invasion [5,6].
Figure 4 Median fluorescence intensity (MFI) values reflecting IgG levels against α-toxin and SSL1 in 31 piglets classified per MRSA
carrier group over a 6-week period. Each dot represents a single piglet, green squares represent intermittent MRSA carriers (n = 16); blue
diamonds represent persistent MRSA carriers (n = 8), red triangles represent non-MRSA carriers (n = 7). Median IgG levels are indicated by
horizontal lines.
Figure 5 Mean of the median fluorescence intensity (MFI) values reflecting IgG levels for ClfA, ClfB, ETB and FnbpB per MRSA carrier
group over time. Green squares represent intermittent MRSA carriers (n = 16); blue diamonds represent persistent MRSA carriers (n = 8), red
triangles represent non-MRSA carriers (n = 7). Data are presented as mean±95% CI. ↑: MRSA introduction.
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though the corresponding genes were not detected on the
microarray in the investigated S. aureus strains. Hence, it
must be noted that the microarray technology used here
bears some limitation as it only detects genes matching
the probes printed on the array. Given that this composi-
te multi-strain array covers allelic variants of genes of
S. aureus genomes of diverse human and bovine lineages,
allelic variants specific for porcine ST398 and ST9 strains
might be missing [14,15,26]. For example, Schijffelen [27]
reported that a scn gene homologue encoding SCIN was
present on a novel ‘animal-specific’ staphylococcal patho-
genicity island (SaPI-S0385), in MRSA ST398 strain S0385
that was not included on the array. Similarly, a chp gene
homologue coding for Fprl1 inhibitory protein (Flipr) [28],
a CHIPS homologue, has been described in MRSA ST398
strain S0385. Another explanation might be that other non-
S. aureus staphylococcal species, present on the piglets’
mucosae, express S. aureus like antigens. Several studies
reported a high occurrence of non-S. aureus staphylococci
in the nares of pigs [29-32] and it has been shown that
staphylococcal species share a common reservoir of viru-
lence factors [33-35]. Notably, S. aureus and Staphylococcus
hyicus, a pathogen causing exudative epidermitis in pigs
and a staphylococcal species commonly found in pigs’ en-
dogenous flora [29,36], carry related ETB [33], which might
explain the high IgG levels observed in a 38-day-old animal
in the present study though ETB was absent in the investi-
gated S. aureus strains.
On the contrary, IgG levels against several enterotox-
ins (i.e. SEI, SEO, SEN) – encoded on the enterotoxin
gene cluster (egc) – were nearly absent though genes
coding for these factors were present in the investigated
S. aureus strains. Staphylococcal enterotoxins are likely
to be mainly expressed during infection and less during
colonization, which might explain the absence of anti-
bodies in sera from healthy pigs. Antibodies against egc
enterotoxins are also rarely detected in sera from healthy
humans [37].
The introduction of MRSA strain C26 at weaning
appeared not to increase the anti-staphylococcal antibody
titers. These observations indicate a low immunogenic po-
tential of strain C26 during colonization. However, since
the observational period is at weaning, maternal anti-
bodies might have interfered with the piglets’ response
[20,21]. Furthermore, conventional pigs naturally colo-
nized with S. aureus and having normal microbiota, in-
cluding various staphylococcal species [30,38], were used
in the present study. Though our trial resembles MRSA
colonization as noticed in the field situation on many pig
herds [9,25], using such pigs complicates the interpret-
ation of the immune response against the MRSA ST398
strain used here. Indeed, in the present study, IgG levels
directed against ClfA, ClfB and FnbpB were significantlylower in persistent MRSA carriers and/or intermittent
MRSA carriers compared to non-MRSA carriers at 38 days
of age. This might indicate that MRSA ST398 strain C26
suppresses systemic antibody responses against certain S.
aureus antigens thus possibly facilitating its colonization.
However, since extensive inter-individual differences were
observed, these significant effects appeared to result from
few animals for ClfA and FnbpB. Future studies with
caesarean-derived colostrum-deprived piglets may help to
further elucidate the immune response associated with
MRSA colonization, although this is a more artificial model
[39]. In addition, the immunogenic potential of highly viru-
lent MRSA clones such as the community-associated
MRSA-like ST8 clone, known as USA300, recently isolated
from pigs in Peru [40] and USA [41], are interesting issues
to consider in further studies. In that way, the effect of
strongly immunogenic extracellular toxins such as Panton-
Valentine leukocidin, a cytotoxin which is probably asso-
ciated with necrotizing lesion development, and additional
enterotoxins on the humoral immune response of piglets
could be studied.
Since the focus has been set on serum IgG which domi-
nates the systemic immunity, the possible role of IgA
involved in the mucosal immune system, remains to be
investigated [20,42-44]. Also, the cellular immune re-
sponse after S. aureus colonization should be investigated.
In conclusion, this is the first report on the humoral im-
mune response in weaned pigs colonized with S. aureus.
Antibody titers directed against MSCRAMM increased
over time whereas antibody titers directed against
staphylococcal toxins or immune-modulating proteins
decreased, which might partly reflect the role of specific
antigens in S. aureus colonization. The introduction of
MRSA ST398 did not elicit a significant humoral immune
reaction. The presence of maternally derived immunity
and other staphylococcal species in the piglets’ microbiota
may have influenced the results of the present study.
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